Contact: Kenza Hadj-Moussa, 612-386-9556
May 8, 2020
TakeAction Minnesota Statement on Prescription Drug Transparency Act Expected to Pass the House Tomorrow
St. Paul, MN—On Saturday, the Minnesota House is expected to pass the Prescription Drug Transparency Act, authored by physician and state Representative Kelly Morrison. The bill requires drug manufacturers to submit drug price information to the commissioner of health. After Saturday’s House floor vote, the bill is on its way to the Governor’s desk.
TakeAction Minnesota released the following statement:
“We applaud the state’s progress on Minnesota’s Prescription Drug Transparency Act. This bill is a step in the right direction and cracks the door on additional reforms to address drug affordability in the state. For too long, pharmaceutical corporations have gotten away with price-gouging lifesaving medication and demanding that Americans pay out of control drug prices. Medicine doesn’t work if people cannot afford it, but we can change the rules.”
Before the COVID19 outbreak, the House considered a number of significant bills that would address high drug costs and affordability challenges including the establishment of a Prescription Drug Affordability Commission, laws to address price-gouging, and systems for the state to negotiated publicly purchased drugs through a unified prescription drug benefits package. Policy recommendations to lower drug prices were released earlier this year by the Attorney General’s task force.
TakeAction Minnesota is a statewide, independent, multiracial people’s organization working to advance democracy and equity through organizing, political action, and campaigns. Offices are located in St. Paul, St. Cloud, and Duluth.